Try our beta test site
12 studies found for:    Open Studies | "Hereditary Breast and Ovarian Cancer Syndrome"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer
Condition: Hereditary Breast and Ovarian Cancer
Intervention: Behavioral: Genetic Counseling and Testing YouTube Video
2 Not yet recruiting Women at Risk of Breast Cancer and OLFM4
Condition: Hereditary Breast and Ovarian Cancer Syndrome
Intervention: Biological: OLFM4
3 Recruiting The Women Choosing Surgical Prevention (WISP) Trial
Condition: Hereditary Breast and Ovarian Cancer Syndrome
Interventions: Procedure: Salpingectomy;   Procedure: Oophorectomy;   Behavioral: Questionnaires
4 Recruiting Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk
Condition: Hereditary Breast and Ovarian Cancer Syndrome
Intervention: Behavioral: psychoeducation
5 Not yet recruiting Neoadjuvant Carboplatin in Triple Negative Breast Cancer
Condition: BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
Interventions: Drug: Doxorubicin;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Cyclophosphamide
6 Recruiting Cancer Genetics Hereditary Cancer Panel Testing
Condition: Hereditary Breast and Ovarian Cancer
Interventions: Other: Questionnaires;   Other: Blood Draw and Baseline Questionnaire
7 Recruiting Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers
Condition: Hereditary Breast and Ovarian Cancer
Intervention: Behavioral: Structured exercise training plus mediterranean diet
8 Not yet recruiting Inherited Susceptible Genes Among Epithelial Ovarian Cancer
Conditions: Ovarian Neoplasm Epithelial;   Hereditary Breast and Ovarian Cancer Syndrome
Intervention:
9 Recruiting Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Conditions: Breast Cancer;   Hereditary Breast and Ovarian Cancer
Intervention:
10 Not yet recruiting Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199
Conditions: Fallopian Tube Carcinoma;   Hereditary Breast and Ovarian Cancer Syndrome;   Ovarian Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Procedure: Evaluation of Cancer Risk Factors;   Other: Medical Chart Review;   Other: Study of Socioeconomic and Demographic Variables
11 Recruiting Familial Investigations of Childhood Cancer Predisposition
Conditions: Acute Leukemia;   Adenomatous Polyposis;   Adrenocortical Carcinoma;   AML;   BAP1 Tumor Predisposition Syndrome;   Carney Complex;   Choroid Plexus Carcinoma;   Constitutional Mismatch Repair Deficiency Syndrome;   Diamond-Blackfan Anemia;   DICER1 Syndrome;   Dyskeratosis Congenita;   Emberger Syndrome;   Familial Acute Myeloid Leukaemia;   Familial Adenomatous Polyposis;   Fanconi Anemia;   Familial Cancer;   Familial Wilms Tumor;   Familial Neuroblastoma;   GIST;   Hereditary Breast and Ovarian Cancer;   Hereditary Paraganglioma-Pheochromocytoma Syndrome;   Hodgkin Lymphoma;   Juvenile Polyposis;   Li-Fraumeni Syndrome;   Lynch Syndrome;   MDS;   Melanoma Syndrome;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Neuroblastoma;   Neurofibromatosis Type 1;   Neurofibromatosis Type II;   Nevoid Basal Cell Carcinoma Syndrome;   Non Hodgkin Lymphoma;   Noonan Syndrome and Other Rasopathy;   Overgrowth Syndromes;   Pancreatic Cancer;   Peutz-Jeghers Syndrome;   Pheochromocytoma/Paraganglioma;   PTEN Hamartoma Tumor Syndrome;   Retinoblastoma;   Rhabdoid Tumor Predisposition Syndrome;   Rhabdomyosarcoma;   Rothmund-Thomson Syndrome;   Tuberous Sclerosis;   Von Hippel-Lindau Disease
Intervention:
12 Recruiting A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer
Conditions: Ovarian Cancer;   Breast Cancer;   Prostate Cancer
Intervention: Drug: LY2606368

Study has passed its completion date and status has not been verified in more than two years.